Opposing effects of aspirin and acetaminophen use on risk of adult acute leukemia

Leukemia Research

Volumn 30, Issue 2, 2006, Pages 164-169

  Weiss, Joli R ^a   Baker, Julie A ^a   Baer, Maria R ^a   Menezes, Ravi J ^a   Nowell, Susan ^a   Moysich, Kirsten B ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Acetaminophen; Acute leukemia; Acute lymphocytic leukemia; Acute myeloid leukemia; Analgesics; Aspirin

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; PARACETAMOL;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; BLOOD DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; FEMALE; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENTIATION;

ACETAMINOPHEN; ADULT; AGED; ASPIRIN; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS;

EID: 28844503931     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.06.023     Document Type: Article

References (46)

1. D. Hoelzer, and N. Gokbuget E. Henderson T. Lister M. Greaves Acute lymphoblastic leukemia in adults in leukemia 7th ed. 2002 Saunders Philadelphia
2. M. Horwitz P.H. Wiernik Epidemiology and genetics of acute and chronic leukemia in American Cancer Society Atlas of Clinical Oncology: adult leukemias 2001 BC Decker, Inc. Hamilton
3. J.P. Collet, C. Sharpe, and E. Belzile Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing Br J Cancer 81 1 1999 62 68
4. L. Rosenberg, C. Louik, and S Shapiro Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma Cancer 82 12 1998 2326 2333
5. M.J. Thun Aspirin and gastrointestinal cancer Adv Exp Med Biol 400A 1997 395 402
6. L.J. Marnett Aspirin and related nonsteroidal anti-inflammatory drugs as chemopreventive agents against colon cancer Prev Med 24 2 1995 103 106
7. D.C. Farrow, T.L. Vaughan, and P.D. Hansten Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer Cancer Epidemiol Biomarkers Prev 7 2 1998 97 102
8. E.M. Funkhouser, and G.B. Sharp Aspirin and reduced risk of esophageal carcinoma Cancer 76 7 1995 1116 1119
9. D. Zaridze, E. Borisova, D. Maximovitch, and V. Chkhikvadze Aspirin protects against gastric cancer: results of a case-control study from Moscow, Russia Int J Cancer 82 4 1999 473 476
10. K.B. Moysich, C. Mettlin, and M.S. Piver Regular use of analgesic drugs and ovarian cancer risk Cancer Epidemiol Biomarkers Prev 10 8 2001 903 906
11. L. Rosenberg, J.R. Palmer, and R.S. Rao A case-control study of analgesic use and ovarian cancer Cancer Epidemiol Biomarkers Prev 9 9 2000 933 937
12. A. Akhmedkhanov, P. Toniolo, and A. Zeleniuch-Jacquotte Aspirin and epithelial ovarian cancer Prev Med 33 6 2001 682 687
13. D.M. Schreinemachers, and R.B. Everson Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 2 1994 138 146
14. P.F. Coogan, S.R. Rao, and L. Rosenberg The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer Prev Med 29 2 1999 72 76
15. R.E. Harris, K.K. Namboodiri, and W.B. Farrar Nonsteroidal antiinflammatory drugs and breast cancer Epidemiology 7 2 1996 203 205
16. S. Subongkot, D. Frame, W. Leslie, and D. Drajer Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment Pharmacotherapy 23 1 2003 9 28
17. M.J. Thun, S.J. Henley, and C. Patrono Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues J Natl Cancer Inst 94 4 2002 252 266
18. R.A. Gupta, and R.N. DuBois Aspirin, NSAIDS, and colon cancer prevention: mechanisms? Gastroenterology 114 5 1998 1095 1098
19. S.J. Shiff, and B. Rigas The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs) J Exp Med 190 4 1999 445 450
20. L.J. Roberts II, and J.D. Morrow Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout J.G. Hardman L.E. Limbird The pharmacological basis of therapeutics 2001 McGraw-Hill New York
21. C.M. Kasum, C.K. Blair, A.R. Folsom, and J.A. Ross Non-steroidal anti-inflammatory drug use and risk of adult leukemia Cancer Epidemiol Biomarkers Prev 12 6 2003 534 537
22. G. Traversa, F. Menniti-Ippolito, and R. Da Cas Drug use and acute leukemia Pharmacoepidemiol Drug Saf 7 2 1998 113 123
23. J.M. Bennett, D. Catovsky, and M.T. Daniel Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group Ann Intern Med 103 4 1985 620 625
24. J.M. Bennett, D. Catovsky, and M.T. Daniel The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations Br J Haematol 47 4 1981 553 561
25. L. Klampfer, J. Cammenga, H.G. Wisniewski, and S.D. Nimer Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines Blood 93 7 1999 2386 2394
26. E. Kopp, and S. Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science 265 5174 1994 956 959
27. M.J. Yin, Y. Yamamoto, and R.B. Gaynor The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta Nature 396 6706 1998 77 80
28. A.S. Baldwin Jr. Series introduction: the transcription factor NF-kappaB and human disease J Clin Invest 107 1 2001 3 6
29. B. Baumgartner, M. Weber, and M. Quirling Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts Leukemia 16 10 2002 2062 2071
30. M.L. Guzman, S.J. Neering, and D. Upchurch Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells Blood 98 8 2001 2301 2307
31. U. Rannug, J.A. Holme, and J.K. Hongslo International commission for protection against environmental mutagens and carcinogens. An evaluation of the genetic toxicity of paracetamol Mutat Res 327 1-2 1995 179 200
32. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Paracetamol (acetaminophen) IARC Monogr Eval Carcinog Risks Hum 50 1990 307 332
33. D.W. Cramer, B.L. Harlow, and L. Titus-Ernstoff Over-the-counter analgesics and risk of ovarian cancer Lancet 351 9096 1998 104 107
34. J.K. McLaughlin, W.J. Blot, E.S. Mehl, and J.F. Fraumeni Jr. Relation of analgesic use to renal cancer: population-based findings Natl Cancer Inst Monogr 69 1985 217 222
35. S. Friis, G.L. Nielsen, and L. Mellemkjaer Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study Int J Cancer 97 1 2002 96 101
36. J.M. Piper, J. Tonascia, and G.M. Matanoski Heavy phenacetin use and bladder cancer in women aged 20 to 49 years N Engl J Med 313 5 1985 292 295
37. L.E. Derby, and H. Jick Acetaminophen and renal and bladder cancer Epidemiology 7 4 1996 358 362
38. M. Gago-Dominguez, J.M. Yuan, J.E. Castelao, R.K. Ross, and M.C. Yu Regular use of analgesics is a risk factor for renal cell carcinoma Br J Cancer 81 3 1999 542 548
39. J.A. Kaye, M.W. Myers, and H. Jick Acetaminophen and the risk of renal and bladder cancer in the general practice research database Epidemiology 12 6 2001 690 694
40. J.A. Baker, J.R. Weiss, and M.S. Czuczman Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma Cancer Causes Control 16 2005 301 308
41. E.T. Chang, T. Zheng, and E.G. Weir Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study J Natl Cancer Inst 96 4 2004 305 315
42. T.L. Cornelison, N. Natarajan, M.S. Piver, and C.J. Mettlin Tubal ligation and the risk of ovarian carcinoma Cancer Detect Prev 21 1 1997 1 6
43. O. Suh, C. Mettlin, and N.J. Petrelli Aspirin use, cancer, and polyps of the large bowel Cancer 72 4 1993 1171 1177
44. C. Mettlin, I. Croghan, N. Natarajan, and W. Lane The association of age and familial risk in a case-control study of breast cancer Am J Epidemiol 131 6 1990 973 983
45. C. Mettlin, N. Natarajan, and R. Huben Vasectomy and prostate cancer risk Am J Epidemiol 132 6 1990 1056 1061 [discussion 1062-5]
46. C. Mettlin Milk drinking, other beverage habits, and lung cancer risk Int J Cancer 43 4 1989 608 612